What to Do with Erosive, Inflammatory Osteoarthritis
Canada Approves Erelzi for PsA; Plus FDA Moves to Increase Access to Naloxone
Study Says 1 Biosimilar Switch Is OK; Jury Still Out on Multiple Switches
Etanercept Biosimilar Is Effective, Well-Tolerated for Rheumatoid Arthritis
Etanercept’s New Autoinjection System; Plus FDA Approves Ixekizumab for Active PsA
Sequential Therapy May Reduce Hip Fracture Risk; Plus New Biosimilar Available in Canada
TNF Inhibitor Drug Tapering Successful in Some Patients with RA
Anti-TNF-Alpha Agents May Improve Endothelial Function Patients with RA
Anti-Drug Antibodies May Affect RA Treatment
- 1
- 2
- 3
- 4
- Next Page »